Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-14 · accession 0001787306-24-000106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-18 | 2024-06-14 | ARQT | Leonard Keith R | Dir | A - Grant | $0.00 | +10.1K | 18.8K | +117% | $0 |
| D | 2024-06-18 | 2024-06-14 | ARQT | Leonard Keith R | Dir | A - Grant | $0.00 | +27.1K | 27.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | A | A | 10,139 | $0.00 | 18,826 | D | — | — | (F1) Represents Restricted Stock Units {"RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-14 | A | A | 27,052 | $0.00 | 27,052 | D | $8.63 · — to 2034-06-14 | 27,052 Common Stock | (F3) The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service. |